IMMUNOLOGY FOR A NEW FUTURE
Nuravax’s mission is to develop effective and affordable preventative treatments for Alzheimer’s and other currently untreatable diseases.
© 2021 Nuravax | Copyright
01
BIOTECH COMPANY
OUR SCIENCE
Nuravax has accepted the challenge to prevent or cure diseases of the central nervous system starting with Alzheimer’s as its primary focus. Nuravax is developing a wide spectrum of products based on its universal MultiTEP vaccine platform, a solution to most problems scientists face when working with CNS diseases
02
PIPELINE
It has taken almost 20 years to develop and characterize Nuravax’s 3rd generation platform. We have developed multiple vaccines for elderly people at risk of Alzheimer’s Disease, tauopathies, Parkinson’s Disease, and α-synucleopathies using mostly NIA and NINDS R21s, R01s, and U01 awards. Based on our data, NIA leadership recently supported the development of a SARS-CoV-2 MultiTEP-based vaccine for the elderly
03
PIPELINE
PUBLICATIONS
Our team members have published a large number of studies
04
NEWS
05
NEWS
CONTACT
info@nuravax.com
E-mail
06